10 20 30 40 50 60 70 80 2OBJ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 19-DEC-06 2OBJ
TITLE CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH TITLE 2 INHIBITOR
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE COMPND 3 PIM-1; COMPND 4 CHAIN: A; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A
KEYWDS PIM, PIM-1, PIM1, HUMAN PIM-1 KINASE, SERINE/THREONINE KEYWDS 2 KINASE, KINASE INHIBITOR COMPLEX, PYRIDONE, KINASE KEYWDS 3 INHIBITOR, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR N.YAO,I.W.CHENEY,S.YAN
REVDAT 3 24-FEB-09 2OBJ 1 VERSN REVDAT 2 06-MAR-07 2OBJ 1 JRNL REVDAT 1 06-FEB-07 2OBJ 0
JRNL AUTH I.W.CHENEY,S.YAN,T.APPLEBY,H.WALKER,T.VO,N.YAO, JRNL AUTH 2 R.HAMATAKE,Z.HONG,J.Z.WU JRNL TITL IDENTIFICATION AND STRUCTURE-ACTIVITY JRNL TITL 2 RELATIONSHIPS OF SUBSTITUTED PYRIDONES AS JRNL TITL 3 INHIBITORS OF PIM-1 KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 1679 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17251021 JRNL DOI 10.1016/J.BMCL.2006.12.086
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 500.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 14369 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1436 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2228 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 68 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2OBJ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-DEC-06. REMARK 100 THE RCSB ID CODE IS RCSB040928.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC BLUE MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16917 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 500.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 8.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1XQZ REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M AMMONIUM PHOSPHATE (DIBASIC), REMARK 280 300MM NACL, 100MM CITRATE BUFFER, PH 5.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 296K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.88467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.94233 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.41350 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 13.47117 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 67.35583 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 LEU A 2 REMARK 465 LEU A 3 REMARK 465 SER A 4 REMARK 465 LYS A 5 REMARK 465 ILE A 6 REMARK 465 ASN A 7 REMARK 465 SER A 8 REMARK 465 LEU A 9 REMARK 465 ALA A 10 REMARK 465 HIS A 11 REMARK 465 LEU A 12 REMARK 465 ARG A 13 REMARK 465 ALA A 14 REMARK 465 ALA A 15 REMARK 465 PRO A 16 REMARK 465 CYS A 17 REMARK 465 ASN A 18 REMARK 465 ASP A 19 REMARK 465 LEU A 20 REMARK 465 HIS A 21 REMARK 465 ALA A 22 REMARK 465 THR A 23 REMARK 465 LYS A 24 REMARK 465 LEU A 25 REMARK 465 ALA A 26 REMARK 465 PRO A 27 REMARK 465 GLY A 28 REMARK 465 LYS A 29 REMARK 465 GLU A 30 REMARK 465 LYS A 31 REMARK 465 GLU A 32 REMARK 465 SER A 306 REMARK 465 LEU A 307 REMARK 465 SER A 308 REMARK 465 PRO A 309 REMARK 465 GLY A 310 REMARK 465 PRO A 311 REMARK 465 SER A 312 REMARK 465 LYS A 313
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 49 72.41 -119.06 REMARK 500 GLU A 79 -40.08 -148.54 REMARK 500 LEU A 80 173.21 57.88 REMARK 500 PRO A 81 85.93 -51.34 REMARK 500 ASN A 82 -28.81 167.10 REMARK 500 SER A 98 -175.29 179.08 REMARK 500 SER A 101 47.12 -99.49 REMARK 500 ASP A 108 174.20 179.01 REMARK 500 ASP A 167 43.76 -148.42 REMARK 500 ASP A 186 81.59 65.58 REMARK 500 ALA A 191 160.27 177.14 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VRV A 400
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XQZ RELATED DB: PDB
DBREF 2OBJ A 1 313 UNP P11309 PIM1_HUMAN 92 404
SEQADV 2OBJ MET A -19 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ GLY A -18 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ SER A -17 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ SER A -16 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ HIS A -15 UNP P11309 EXPRESSION TAG SEQADV 2OBJ HIS A -14 UNP P11309 EXPRESSION TAG SEQADV 2OBJ HIS A -13 UNP P11309 EXPRESSION TAG SEQADV 2OBJ HIS A -12 UNP P11309 EXPRESSION TAG SEQADV 2OBJ HIS A -11 UNP P11309 EXPRESSION TAG SEQADV 2OBJ HIS A -10 UNP P11309 EXPRESSION TAG SEQADV 2OBJ SER A -9 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ SER A -8 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ GLY A -7 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ LEU A -6 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ VAL A -5 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ PRO A -4 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ ARG A -3 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ GLY A -2 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ SER A -1 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ HIS A 0 UNP P11309 CLONING ARTIFACT SEQADV 2OBJ SEP A 261 UNP P11309 SER 352 MODIFIED RESIDUE
SEQRES 1 A 333 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 333 LEU VAL PRO ARG GLY SER HIS MET LEU LEU SER LYS ILE SEQRES 3 A 333 ASN SER LEU ALA HIS LEU ARG ALA ALA PRO CYS ASN ASP SEQRES 4 A 333 LEU HIS ALA THR LYS LEU ALA PRO GLY LYS GLU LYS GLU SEQRES 5 A 333 PRO LEU GLU SER GLN TYR GLN VAL GLY PRO LEU LEU GLY SEQRES 6 A 333 SER GLY GLY PHE GLY SER VAL TYR SER GLY ILE ARG VAL SEQRES 7 A 333 SER ASP ASN LEU PRO VAL ALA ILE LYS HIS VAL GLU LYS SEQRES 8 A 333 ASP ARG ILE SER ASP TRP GLY GLU LEU PRO ASN GLY THR SEQRES 9 A 333 ARG VAL PRO MET GLU VAL VAL LEU LEU LYS LYS VAL SER SEQRES 10 A 333 SER GLY PHE SER GLY VAL ILE ARG LEU LEU ASP TRP PHE SEQRES 11 A 333 GLU ARG PRO ASP SER PHE VAL LEU ILE LEU GLU ARG PRO SEQRES 12 A 333 GLU PRO VAL GLN ASP LEU PHE ASP PHE ILE THR GLU ARG SEQRES 13 A 333 GLY ALA LEU GLN GLU GLU LEU ALA ARG SER PHE PHE TRP SEQRES 14 A 333 GLN VAL LEU GLU ALA VAL ARG HIS CYS HIS ASN CYS GLY SEQRES 15 A 333 VAL LEU HIS ARG ASP ILE LYS ASP GLU ASN ILE LEU ILE SEQRES 16 A 333 ASP LEU ASN ARG GLY GLU LEU LYS LEU ILE ASP PHE GLY SEQRES 17 A 333 SER GLY ALA LEU LEU LYS ASP THR VAL TYR THR ASP PHE SEQRES 18 A 333 ASP GLY THR ARG VAL TYR SER PRO PRO GLU TRP ILE ARG SEQRES 19 A 333 TYR HIS ARG TYR HIS GLY ARG SER ALA ALA VAL TRP SER SEQRES 20 A 333 LEU GLY ILE LEU LEU TYR ASP MET VAL CYS GLY ASP ILE SEQRES 21 A 333 PRO PHE GLU HIS ASP GLU GLU ILE ILE ARG GLY GLN VAL SEQRES 22 A 333 PHE PHE ARG GLN ARG VAL SER SEP GLU CYS GLN HIS LEU SEQRES 23 A 333 ILE ARG TRP CYS LEU ALA LEU ARG PRO SER ASP ARG PRO SEQRES 24 A 333 THR PHE GLU GLU ILE GLN ASN HIS PRO TRP MET GLN ASP SEQRES 25 A 333 VAL LEU LEU PRO GLN GLU THR ALA GLU ILE HIS LEU HIS SEQRES 26 A 333 SER LEU SER PRO GLY PRO SER LYS
MODRES 2OBJ SEP A 261 SER PHOSPHOSERINE
HET SEP A 261 10 HET VRV A 400 23
HETNAM SEP PHOSPHOSERINE HETNAM VRV 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2- HETNAM 2 VRV DIHYDROPYRIDINE-3-CARBONITRILE
HETSYN SEP PHOSPHONOSERINE
FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 VRV C18 H11 BR N2 O2 FORMUL 3 HOH *68(H2 O)
HELIX 1 1 PRO A 33 GLN A 37 1 5 HELIX 2 2 MET A 88 SER A 97 1 10 HELIX 3 3 LEU A 129 GLY A 137 1 9 HELIX 4 4 GLN A 140 CYS A 161 1 22 HELIX 5 5 LYS A 169 GLU A 171 5 3 HELIX 6 6 THR A 204 SER A 208 5 5 HELIX 7 7 PRO A 209 HIS A 216 1 8 HELIX 8 8 HIS A 219 GLY A 238 1 20 HELIX 9 9 HIS A 244 GLY A 251 1 8 HELIX 10 10 SER A 260 LEU A 271 1 12 HELIX 11 11 ARG A 274 ARG A 278 5 5 HELIX 12 12 THR A 280 ASN A 286 1 7 HELIX 13 13 HIS A 287 GLN A 291 5 5 HELIX 14 14 LEU A 295 LEU A 304 1 10
SHEET 1 A 3 TYR A 38 GLN A 39 0 SHEET 2 A 3 GLY A 50 ARG A 57 -1 O ILE A 56 N GLN A 39 SHEET 3 A 3 LEU A 43 GLY A 47 -1 N GLY A 45 O VAL A 52 SHEET 1 B 5 TYR A 38 GLN A 39 0 SHEET 2 B 5 GLY A 50 ARG A 57 -1 O ILE A 56 N GLN A 39 SHEET 3 B 5 PRO A 63 GLU A 70 -1 O ILE A 66 N TYR A 53 SHEET 4 B 5 SER A 115 GLU A 121 -1 O LEU A 120 N ALA A 65 SHEET 5 B 5 LEU A 106 GLU A 111 -1 N LEU A 107 O ILE A 119 SHEET 1 C 2 TRP A 77 GLY A 78 0 SHEET 2 C 2 VAL A 86 PRO A 87 -1 O VAL A 86 N GLY A 78 SHEET 1 D 3 VAL A 126 ASP A 128 0 SHEET 2 D 3 ILE A 173 ASP A 176 -1 O ILE A 175 N GLN A 127 SHEET 3 D 3 GLU A 181 LEU A 184 -1 O GLU A 181 N ASP A 176 SHEET 1 E 2 VAL A 163 LEU A 164 0 SHEET 2 E 2 ALA A 191 LEU A 192 -1 O ALA A 191 N LEU A 164
LINK C SER A 260 N SEP A 261 1555 1555 1.32 LINK C SEP A 261 N GLU A 262 1555 1555 1.33
CISPEP 1 GLU A 124 PRO A 125 0 -0.07
SITE 1 AC1 11 GLY A 45 SER A 46 ALA A 65 LYS A 67 SITE 2 AC1 11 ILE A 104 LEU A 120 GLU A 121 LEU A 174 SITE 3 AC1 11 ILE A 185 ASP A 186 HOH A 464
CRYST1 97.264 97.264 80.827 90.00 90.00 120.00 P 65 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010281 0.005936 0.000000 0.00000
SCALE2 0.000000 0.011872 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012372 0.00000